We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

137 hedge funds and large institutions have $573M invested in Five Prime Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 31

58% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 19

9% more funds holding

Funds holding: 126 → 137 (+11)

41% less call options, than puts

Call options by funds: $2.14M | Put options by funds: $3.64M

43% less capital invested

Capital invested by funds: $1B → $573M (-$428M)

Holders
137
Holders Change
+11
Holders Change %
+8.73%
% of All Funds
3.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
52
Reduced
31
Closed
19
Calls
$2.14M
Puts
$3.64M
Net Calls
-$1.5M
Net Calls Change
-$597K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$23.6M
2
DM
Deerfield Management
New York
+$14.5M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$14.5M
4
Victory Capital Management
Victory Capital Management
Texas
+$12.6M
5
Morgan Stanley
Morgan Stanley
New York
+$9.6M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$36.4M
2
HM
HealthCor Management
New York
-$29.3M
3
EAM
Eventide Asset Management
Massachusetts
-$9.2M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.18M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
76
AQR Capital Management
Connecticut
$444K +$331K +10,287 +103%
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$438K – – –
ProShare Advisors
78
ProShare Advisors
Maryland
$430K +$47.4K +1,474 +8%
Russell Investments Group
79
Russell Investments Group
United Kingdom
$425K -$35.4K -1,101 -6%
BBA
80
Baker Bros. Advisors
New York
$422K – – –
AIG
81
American International Group
New York
$401K +$2.77K +86 +0.5%
FRM
82
Fox Run Management
Connecticut
$386K +$566K +17,614 New
VEA
83
Virtus ETF Advisers
New York
$381K +$206K +6,405 +58%
VFA
84
Virtus Fund Advisers
Connecticut
$381K +$559K +17,371 New
State Board of Administration of Florida Retirement System
85
State Board of Administration of Florida Retirement System
Florida
$363K +$9K +280 +2%
Tudor Investment Corp
86
Tudor Investment Corp
Connecticut
$362K +$205K +6,363 +63%
CCMH
87
Cornerstone Capital Management Holdings
New York
$341K -$367K -11,400 -42%
Invesco
88
Invesco
Georgia
$332K +$21.4K +666 +5%
FAM
89
Fred Alger Management
New York
$307K -$129K -4,000 -22%
Legal & General Group
90
Legal & General Group
United Kingdom
$298K +$105K +3,277 +32%
MIM
91
MetLife Investment Management
New Jersey
$294K +$432K +13,422 New
UCFA
92
United Capital Financial Advisors
Texas
$276K – – –
VOYA Investment Management
93
VOYA Investment Management
Georgia
$276K – – –
TD Asset Management
94
TD Asset Management
Ontario, Canada
$252K +$370K +11,500 New
UBS Group
95
UBS Group
Switzerland
$248K +$133K +4,126 +58%
Ameriprise
96
Ameriprise
Minnesota
$231K +$339K +10,536 New
Teacher Retirement System of Texas
97
Teacher Retirement System of Texas
Texas
$221K +$324K +10,073 New
CSS
98
Cubist Systematic Strategies
Connecticut
$215K +$291K +9,060 +1,211%
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
$198K -$331K -10,289 -53%
Barclays
100
Barclays
United Kingdom
$154K -$99.1K -3,082 -30%
2 3
4
5 6

FPRX Hedge Fund Activity: Q4 2017 in Review

137 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2017, worth a combined $573M — down 43% from $1B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new FPRX positions and 19 closed out — a net gain of 11 holders — while 52 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $23.6M. The largest seller was Adage Capital Partners, cutting an estimated $36.4M.

  • 137 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2017, up from 126 in Q3 2017.
  • Funds reported $573M of Five Prime Therapeutics, Inc. stock for Q4 2017, down 43% quarter-over-quarter.
  • 30 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2017 and 19 closed out, a net change of +11 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q4 2017 was State Street, an estimated $23.6M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q4 2017 was Adage Capital Partners, an estimated $36.4M sold.

Based on aggregated 13F filings for Q4 2017.